CT 112
/ Nuo Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 28, 2015
Spironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patients.
(PubMed)
- "Spironolactone treatment in hemodialysis patients was secure and effective in regression of left ventricular hypertrophy, a major risk factor for cardiovascular events in these patients. This effect occurred in spite of blood pressure stability."
Journal • Biosimilar • Chronic Kidney Disease
1 to 1
Of
1
Go to page
1